The objective of the Retos-Colaboración call is to support cooperative projects between companies and research organisations, with the aim of promoting the development of new technologies, the business application of new ideas and techniques, and contributing to the creation of new products and services.

The call for Challenges-Collaboration aims to stimulate, through the financing of projects, the generation of a critical mass in interdisciplinary R+D+I necessary to advance in the search for solutions in accordance with the priorities established in the Challenges, promote the creation of innovative companies, direct the activity of existing companies towards innovative activity, mobilise private investment, generate employment and improve the country’s technological balance, as well as reinforcing the international leadership capacity of the Spanish Science, Technology and Innovation System and its agents, contributing to improving the competitiveness of the business fabric.

MJN applied for the 2018 call at the beginning of this year together with the University of Girona, specifically with its artificial intelligence department eXit. The final list of funded projects has published this December. In MJN we are very happy to be one of the chosen by the program. In this way, we have obtained resources to continue with the development of MJN-SERAS, our auricular device to assess the risk of epileptic seizures in collaboration with the eXit team. The joint work will allow us to evolve the crisis calculation algorithms, deepen their customization for each person, and adapt them in the best possible way to each user’s mobile device. All this work will continue through 2018, 2019 and 2020.

In MJN we continue working so that our MJN-SERAS device can offer the best results to our future users. In order to do this, the commitment to continuous improvement, innovation and investment in R&D is basic. From these lines, we would like to thank the Ministry of Industry and Innovation and its Collaboration Challenges programme, for having trusted us and the University of Girona.


Find out your risk of having an epilepsy crisis at any time and place.

Leave a Reply

Abrir chat
Contacta con nosotros al momento
Chat con Anna
¡Hola! 👋🏻
Soy Anna, ¿en qué puedo ayudarte?

The user who fills in the information requested in this form declares to be entitled to do so and is solely responsible for the accuracy and completeness of the data and information entered, expressly exonerating MJN NEUROSERVEIS of any liability that may arise for this entity on the occasion of the information provided through this form.

Yes, I accept

L’usuari que complimenta la informació requerida al present formulari declara estar legitimat per això i es fa responsable exclusiu de la veracitat i integritat de les dades i informació que introdueix, exonerant expressament a MJN NEUROSERVEIS de qualsevol responsabilitat que es pugi generar per aquesta entitat amb ocasió de la informació facilitat a través del present formulari.

Si, accepto

El usuario que cumplimenta la información requerida en el presente formulario declara estar legitimado para ello y se hace responsable exclusivo de la veracidad e integridad de los datos e información que introduce, exonerando expresamente a MJN NEUROSERVEIS de cualquier responsabilidad que pudiera generarse para esta entidad con ocasión de la información facilitada a través del presente formulario.

Sí, acepto

Save the date

The next Saturday 21st of November at 4 pm, you will be able to know first hand our product: mjn-SERAS.
mjn-SERAS is a healthcare product that sends a warning signal when the risk of epileptic seizures is high, to the affected person and their trusted contacts.

Sign up now!

    mjn-SERAS is a medical device with CE marking according to the European Directive 93/42/EEC and the Royal Decree RD. 1591/2009.
    Contraindications: Do not use the product if you suffer from an infection in the ear canal or if you suffer from a skin lesion in the vicinity of the product's area of influence.
    Considerations: This medical product works with an APP only on Android phones. The results tested are 96% sensitivity and 94% specificity.

    Save the date

    El próximo sábado 21 de noviembre a las 4 de la tarde, podrás conocer de primera mano nuestro producto: mjn-SERAS.
    mjn-SERAS es un producto sanitario que lanza una señal de aviso cuando el riesgo de crisis de epilepsia es elevado, a la persona afectada y a sus contactos de confianza.


      mjn-SERAS es un producto sanitario con marcado CE conforme a la Directiva Europea 93/42/EEC y el Real Decreto RD. 1591/2009.
      Contraindicaciones: No usar el producto en caso de padecer una infección en el canal auditivo o en caso de padecer una lesión cutánea en las proximidades del área de influencia del producto.
      Consideraciones: Este producto sanitario funciona con una APP solo en teléfonos Android. Los resultados testeados son 96% de sensibilidad y 94% de especificidad.